Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what assessment he has made of whether the level of availability of immunotherapy is consistent with the objectives of the NHS Cancer Plan.
Availability of immunotherapy drugs happens via assessment at the National Institute for Health and Care Excellence (NICE). As they follow the same NICE process as other cancer medicines then all relevant providers are required to implement them in the same timelines as with any newly approved medicine.